Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Lethagen

Showing results (91-100 of 94) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 94 results.
Journal of Thrombosis and Haemostasis : JTH|April 6, 2007
Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD)A Tosetto, F Rodeghiero, G Castaman, et al.
Journal of Thrombosis and Haemostasis : JTH|March 5, 2008
Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD)U Budde, R Schneppenheim, J Eikenboom, et al.
Journal of Thrombosis and Haemostasis : JTH|July 2, 2009
Expression of 14 von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM-1VWD studyJ Eikenboom, L Hilbert, A S Ribba, et al.
Seminars in Hematology|December 6, 2001
Use of recombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombastheniaM C Poon, R d'Oiron, I Hann, et al.
Pageof 10

Showing results (91-100 of 94) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 94 results.
Journal of Thrombosis and Haemostasis : JTH|April 6, 2007
Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD)A Tosetto, F Rodeghiero, G Castaman, et al.
Journal of Thrombosis and Haemostasis : JTH|March 5, 2008
Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD)U Budde, R Schneppenheim, J Eikenboom, et al.
Journal of Thrombosis and Haemostasis : JTH|July 2, 2009
Expression of 14 von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM-1VWD studyJ Eikenboom, L Hilbert, A S Ribba, et al.
Seminars in Hematology|December 6, 2001
Use of recombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombastheniaM C Poon, R d'Oiron, I Hann, et al.
Pageof 10